Abstract:In hemodialyzed patients aluminum (Al) intoxication may induce osteomalacic lesions which are mainly observed when plasma immunoreactive parathyroid hormone (iPTH) concentrations are low, and osteitis fibrosa absent. In this study, the bone tissue of eight hemodialyzed patients with elevated plasma and bone Al concentrations was examined by histomorphometry, electron microscopy, and x-ray microanalysis. Five patients (group 1) had osteomalacia and minimal osteitis fibrosa, three patients (group 2) had severe o… Show more
“…Aluminum is widely recognized as the most effective phosphate‐binding drug but its use is now generally restricted to ESRD patients who are uncontrolled on other agents, owing to concerns about its toxicity, including dialysis encephalopathy,9, 10 osteomalacia,11, 12 and microcytic anaemia 13. Calcium‐based binders largely replaced aluminum in the 1980s and 1990s and have been the mainstay of treatment for many years 14.…”
“…Aluminum is widely recognized as the most effective phosphate‐binding drug but its use is now generally restricted to ESRD patients who are uncontrolled on other agents, owing to concerns about its toxicity, including dialysis encephalopathy,9, 10 osteomalacia,11, 12 and microcytic anaemia 13. Calcium‐based binders largely replaced aluminum in the 1980s and 1990s and have been the mainstay of treatment for many years 14.…”
“…It has recently been explained by a primary effect of aluminum on the affinity of PTH receptor which may be related to exchange of aluminum with magnesium at the G protein level [49]. Furthermore, it should be pointed out that Al was found at high concentration in the mitochondria of intoxicated patients, and that this storage may interfere with the calcium fluxes implicated in the extracellular mineral deposition [50],…”
Section: Evidence For the Responsibility Of Aluminum In Adynamic Bonementioning
“…The accumulation per se of A1 at the mineralization front of bone may not be responsible for the toxic effect of Al; rather a deleterious effect on osteoblasts (Plachot et al 1984;Lieberherr et al 1987;Ott et al 1987;Blair et al 1989), their precursors (Simmons et al 1991) or, alternatively, inhibitory effects on the production or action of parathyroid hormone (Cann et al 1979;Morrissey et al 1983;Henry et al 1984;Bourdeau et al 1987) or 1,25-dihydroxycholecalciferol (Henry & Norman, 1985;Klein et al 1986) may be responsible for the bone abnormalities. In addition, Al may also contribute to the bone lesion by physically interfering with hydroxyapatite formation (Posner et al 1986) or with calcium phosphate crystal formation (Meyer & Thomas, 1986).…”
Section: B O N E a N D P A R A T H Y R O I D G L A N D Smentioning
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.